Zhongsheng Pharmaceutical

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company," "Zhongsheng Pharmaceutical") was founded in 1979. It is a leading pharmaceutical company in China that integrates drug research and development, production, and sales, and is also a top 100 pharmaceutical enterprise in China's pharmaceutical industry and an A-share listed company. The Company adheres to the core value of "putting patients' interests first" and follows its corporate mission of "caring for life with high-quality products and promoting public health with excellent services." Focusing on treatment areas such as ophthalmology, cardiovascular and cerebrovascular diseases, respiratory conditions, and gastroenterology, the Company has established pharmaceutical manufacturing as its core business. It pursues a dual-driven development path of innovation in research and development and marketing, gradually forming a sustainable business system led by innovative drugs, supported by traditional Chinese medicine (TCM) as the foundation, and complemented by chemical generic drugs. The Company is committed to becoming one of China’s premier pharmaceutical and healthcare groups. Its main businesses cover the R&D, production, and sales of TCM, chemical drugs, medicinal herbs and decoction pieces, and chemical active pharmaceutical ingredients, as well as investments in ophthalmology-related industries. The Company owns ten subsidiaries covering pharmaceutical manufacturing, trade, innovative R&D, and ophthalmology investment sectors, with four major production bases located in Dongguan, Guangzhou, Zhaoqing, and Qujing.